報價延遲最少15分鐘:2025/07/07 00:43 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
6.62 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-3,442.80/--
|
|
企業價值
3.94M
|
| 資產負債 |
|
每股賬面淨值
12.79
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
43.49K
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/07 00:43 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S. |